Intrahepatic cholestasis of pregnancy (obstetric cholestasis, ICP)
Bedside summary
ICP is pruritus with raised serum bile acids in pregnancy, resolving after birth. Itching is typically worse on palms and soles and at night, with normal-appearing skin (no primary rash). The main concern is an increased risk of stillbirth that rises steeply when peak total bile acids are >= 100 micromol/L. RCOG Green-top 43 (2022): diagnose with itch of normal skin + peak random total bile acids >= 19 micromol/L. UDCA is NOT routinely recommended to improve perinatal outcomes (PITCHES trial showed no benefit) but may be used for maternal itch/biochemistry. Management centres on bile-acid monitoring and planning timing of birth by severity.
Red flags
- Peak bile acids >= 100 micromol/L (markedly raised stillbirth risk — earlier birth)
- Reduced fetal movements
- Jaundice, right upper quadrant pain, or very high transaminases (consider HELLP, acute fatty liver, hepatitis)
- Raised BP / proteinuria (pre-eclampsia overlap)
- Coagulopathy / bleeding (vitamin K malabsorption)
- Early-onset (< 30 weeks) or rapidly rising bile acids
Assessment
Differential diagnosis
- Other causes of pruritus in pregnancy: eczema, atopic eruption of pregnancy, polymorphic eruption of pregnancy, pemphigoid gestationis (these have a rash)
- Pre-eclampsia / HELLP (check BP, platelets, LFTs)
- Acute fatty liver of pregnancy
- Viral hepatitis, gallstones/biliary obstruction, primary biliary cholangitis
- Drug-induced liver injury
- Allergic/urticarial reaction
Investigations
- Serum total bile acids (random, non-fasting acceptable) — diagnostic if peak >= 19 micromol/L; the level stratifies risk and guides delivery timing
- LFTs (ALT/AST often mildly raised; may be normal), bilirubin
- Repeat bile acids/LFTs regularly (e.g. weekly if moderate/severe) to track peak
- Exclude other causes: viral hepatitis screen, liver ultrasound if atypical, BP + urine protein + FBC/platelets (pre-eclampsia)
- Coagulation if severe/prolonged cholestasis (vitamin K malabsorption)
- CTG/ultrasound do NOT reliably predict or prevent ICP stillbirth — do not rely on them for reassurance
Management
- Confirm diagnosis: pruritus + raised bile acids, with other causes excluded (itching may precede biochemical change — recheck if initially normal)
- Grade severity by PEAK total bile acids: mild < 40, moderate 40-99, severe >= 100 micromol/L
- Monitor bile acids and LFTs serially (track the peak, which drives risk and timing)
- Symptomatic relief of itch: emollients, menthol in aqueous cream; UDCA may modestly help itch/LFTs but does not improve perinatal outcome (discuss)
- Plan timing of birth by peak bile acids: severe (>= 100) consider birth ~35-36 weeks; moderate (40-99) ~38-39 weeks; mild (< 40) ~40 weeks, individualised with other risk factors (twins, GDM, pre-eclampsia) [verify local thresholds]
- Give vitamin K to mother if prolonged prothrombin time / steatorrhoea (malabsorption)
- Counsel re stillbirth risk at high bile-acid levels and the aim of timed birth; advise reporting reduced fetal movements
- Postnatal: recheck LFTs/bile acids ~4+ weeks to confirm resolution (persistent abnormality -> investigate liver disease); advise recurrence risk and avoid oestrogen-based contraception if it provoked symptoms
Drugs & doses
Disposition
Complications & pitfalls
- Stillbirth (risk rises sharply at bile acids >= 100 micromol/L)
- Spontaneous and iatrogenic preterm birth
- Meconium-stained liquor, fetal distress
- Maternal: severe pruritus, sleep deprivation, steatorrhoea, vitamin K-related coagulopathy / postpartum haemorrhage
- Recurrence in future pregnancies (~45-90%)
Exam pearls
- Itchy palms and soles with normal skin + raised bile acids = think ICP.
- Risk is driven by the PEAK bile-acid level; >= 100 micromol/L is the high-risk threshold for timing birth earlier.
- CTG and growth scans do not predict or prevent ICP stillbirth — do not falsely reassure with them.
- UDCA eases itch/LFTs but does not reduce stillbirth (PITCHES); use for symptoms, not fetal protection.
- Itch can precede biochemical changes — recheck bile acids if initially normal and itching persists.
- Confirm resolution postnatally and avoid oestrogen contraception if it triggered symptoms.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.